VACCINE COMPOSITION

The instant invention provides cost effective and immunogenic IPV formulations.The said formulations contain an adjuvant that can enable 5 to 10 fold dose reduction for inactivated polio virus vaccines. La présente invention concerne des formulations de vaccins antipoliomyélitiques inactivés effecti...

Full description

Saved in:
Bibliographic Details
Main Authors JAGDISHPRASAD, GAIROLA SUNIL, MAHESHKUMAR, GAUTAM MANISH, SAKHARAM, JADHAV SURESH
Format Patent
LanguageEnglish
French
Published 23.06.2011
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC
GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINSTCLIMATE CHANGE
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The instant invention provides cost effective and immunogenic IPV formulations.The said formulations contain an adjuvant that can enable 5 to 10 fold dose reduction for inactivated polio virus vaccines. La présente invention concerne des formulations de vaccins antipoliomyélitiques inactivés effectifs et immunogènes. Les formulations contiennent un adjuvant qui peut permettre une réduction de 5 à 10 fois la dose pour les vaccins antipoliomyélitiques inactivés.
Bibliography:Application Number: WO2010IN00814